IL21 and neoplasm: By day 28, vaccination combined with IL-21+ IL-2 again inhibited tumor growth significantly better than vaccination alone (p < 0.0001) and vaccination combined with IL-2 (p = 0.0006) or with IL-21 (p = 0.0033).